Custom recombinant antibody discovery and development services for research, diagnostic, and therapeutic applications. AxioMx can develop novel antibodies, enhance the affinity of existing antibodies, or improve antibody biophysical properties.
|Primary Business Focus||Biotechnology - Non-Pharmaceutical|
|Tom Thompson||VP Sales/Marketing||email available to subscribers|
|Janet Verney||Executive Director|
|Dawn Alderman||Director Automation/Production|
|Margaret Kiss||Director Molecular Sciences|
* Downloads will not contain Personnel E-mail addresses
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of American City Business Journals.